1 / 4

Omeprazole Market is expected to exhibit a CAGR of 5.2% over 2018–2026

The global omeprazole market size was valued at US$ 2,668.4 million in 2017, and is expected to exhibit a CAGR of 5.2% over the forecast period (2018 u2013 2026).

Download Presentation

Omeprazole Market is expected to exhibit a CAGR of 5.2% over 2018–2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Omeprazole Omeprazole Market Size, Share, Trend, Market Size, Share, Trend, Outlook, Future Analysis And Synthesis By Outlook, Future Analysis And Synthesis By 2026 2026 Omeprazole delayed-release capsules in combination with other medications are used to eliminate H. pylori, a bacteria causing ulcers and prevent the development of new ulcers in people with a history of ulcer formation of the small intestine. Prescription omeprazole is also used to treat higher acid producing stomach conditions such as Zollinger-Ellison syndrome in adults. According to the survey by Clinical Gastroenterology and Hepatology, 2012, ZES occurs in about one in every 1 million people, and is more common among men 30 to 50 years old. Market Dynamics Market Dynamics Increasing prevalence of acid related diseases (ARDs) including gastroesophageal reflux disease (GERD) is a major factor driving omeprazole market growth. According to the research survey conducted by Florida Hospitals, 2015, pregnant women are at a higher risk of acid reflux, with an estimated 25% pregnant women experiencing the symptoms. The survey further stated that about 20% of people with acid reflux are at a higher risk of developing gastroesophageal reflux disease (GERD). Furthermore, increase in H.pylori infection and NSAID associated gastric and duodenal ulcers are expected to bolster market growth in the near future. For In-Depth Review | Get Sample Copy @ For In-Depth Review | Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request- https://www.coherentmarketinsights.com/insight/request- sample/2380 sample/2380 Also, launch of low-cost generic versions of omeprazole is expected to fuel market growth. For instance, in 2016, Dr. Reddy’s launched generic version to Zegerid capsules (omeprazole/sodium bicarbonate) for short-term treatment of stomach and duodenal ulcers, erosive esophagitis and heartburn associated with gastroesophageal reflux disease (GERD).

  2. Increasing prevalence of peptic ulcers is expected to propel omeprazole market growth Increasing prevalence of peptic ulcers is expected to propel omeprazole market growth Increasing prevalence of duodenal ulcers is expected to propel growth of the omeprazole market. According to a survey by Virtual Medical Center, 2016, peptic ulcer is the most common disease occurring in about 10-15% of the global population at a time. It is common in men and more common in elderly people. The survey further stated that duodenal ulcers are four times more common than gastric ulcers. Increasing prevalence of H.pylori associated infection and favorable pricing policies to bolster the market Increasing prevalence of H.pylori associated infection and favorable pricing policies to bolster the market growth growth North America is expected to hold a dominant position in the global omeprazole market. This is owing to increasing number of people affected by H.pylori infection, which in turn is expected to increase the risk of gastric and duodenal ulcers. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Health Information Center, 2014, about 30 to 40 percent of people in the U.S. suffer from the H. pylori infection, thus increasing the risk of duodenal and gastric development. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Omeprazole Market Research Objective and Assumption • Omeprazole Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Omeprazole Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Omeprazole Market, By Regions • Omeprazole Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Omeprazole Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Omeprazole Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List.

  3. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Omeprazole Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key Players Key Players Major players operating in the global omeprazole market include, Astrazeneca Plc., Sandoz, Inc., Mylan N.V., Apotex, Inc., Dr. Reddy’s Laboratories, Inc., Impax Laboratories, Inc., Perrigo Company Plc, Santarus, Inc., Watson laboratories, Inc., and Lek Pharmaceuticals d.d. Detailed Segmentation: Detailed Segmentation: Global Omeprazole Market, By Dosage Form: Global Omeprazole Market, By Dosage Form: Capsule • Powder • Tablet • Global Omeprazole Market, By Indication: Global Omeprazole Market, By Indication: Duodenal Ulcer • Gastric Ulcer • Gastroesophageal Reflux Disease (GERD) • Erosive Esophagitis • Others • Browse Complete Research Report @ Browse Complete Research Report @ https://www.coherentmarketinsights.com/market-insight/omeprazole-market-2380 https://www.coherentmarketinsights.com/market-insight/omeprazole-market-2380

  4. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related